We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 3,107 results
  1. In this issue

    Article 19 June 2024
  2. The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior

    Background

    Solitary Fibrous Tumor (SFT) is a distinct soft tissue neoplasm associated with NAB2-STAT6 gene fusion. It can involve a number of anatomic...

    Muhammad Usman Tariq, Nasir Ud Din, ... Yong-Koo Park in Diagnostic Pathology
    Article Open access 20 April 2021
  3. Thematic research clusters in very old populations (≥ 80 years): a bibliometric approach

    Background

    Population aging will be one of humanity’s major challenges in the decades to come. In addition to focusing on the pathologies causing the...

    Gregorio Gonzalez-Alcaide, Sergio Palacios-Fernandez, Jose-Manuel Ramos-Rincon in BMC Geriatrics
    Article Open access 21 April 2021
  4. Performance of ChatGPT on the Taiwan urology board examination: insights into current strengths and shortcomings

    Purpose

    To compare ChatGPT-4 and ChatGPT-3.5's performance on Taiwan urology board examination (TUBE), focusing on answer accuracy, explanation...

    Chung-You Tsai, Shang-Ju Hsieh, ... Pai-Yu Cheng in World Journal of Urology
    Article 23 April 2024
  5. Evaluation of maintenance of the common androgen deprivation therapy with the new antiandrogen therapy in patients with castration-resistant prostate cancer: a systematic review

    Purpose

    Advanced prostate cancer does not respond to traditional androgen deprivation therapy (ADT) at some point in the treatment. The development of...

    Carla Manzoni Salgado, Herney Andrés Garcia-Perdomo, Leonardo O. Reis in International Urology and Nephrology
    Article 06 April 2022
  6. Mixed neuroendocrine–non-neuroendocrine neoplasm of the bile duct with long-term prognosis after neoadjuvant chemotherapy

    A 74-year-old man with obstructive jaundice presented with a thickened distal bile duct wall. A transpapillary forceps biopsy revealed an...

    Shinya Nakamura, Masahiro Serikawa, ... Shiro Oka in Clinical Journal of Gastroenterology
    Article Open access 24 May 2024
  7. Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome

    Background

    Based on molecular characteristics, deficient DNA mismatch repair (dMMR) solid tumors are largely divided into three categories:...

    Tetsuya Ito, Tatsuro Yamaguchi, ... Hideyuki Ishida in International Journal of Clinical Oncology
    Article Open access 14 April 2024
  8. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1–ALK fusions

    Pseudosarcomatous myofibroblastic proliferation is a descriptive term that designates a group of clinically indolent genitourinary lesions that most...

    Andres M. Acosta, Elizabeth G. Demicco, ... Vickie Y. Jo in Modern Pathology
    Article 09 September 2020
  9. Management of the Devastated Bladder Outlet after Prostate CANCER Treatment

    Purpose of Review

    Devastating complications of the bladder outlet resulting from prostate cancer treatments are relatively uncommon. However, the...

    Francisco E. Martins, Nicolaas Lumen, Henriette Veiby Holm in Current Urology Reports
    Article 16 May 2024
  10. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

    This review summarizes the classification of tumors of the adrenal medulla and extra-adrenal paraganglia as outlined in the 5th series of the WHO...

    Ozgur Mete, Sylvia L. Asa, ... Arthur Tischler in Endocrine Pathology
    Article 13 March 2022
  11. Primary MiNEN of the urinary bladder: an hitherto undescribed entity composed of large cell neuroendocrine carcinoma and adenocarcinoma with a distinct clinical behavior

    Neuroendocrine carcinomas (NECs) of the urinary bladder are very rare and can be observed in the context of mixed neuroendocrine/non-neuroendocrine...

    Giacomo Maria Pini, Silvia Uccella, ... Carlo Patriarca in Virchows Archiv
    Article Open access 17 January 2021
  12. Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies

    Background and objective

    Numerous observational studies have been conducted to investigate the potential association between inflammatory bowel...

    Ben‐Gang Zhou, Qi Yu, ... Mei Wang in International Journal of Colorectal Disease
    Article 13 June 2023
  13. Emerging and anticipated innovations in prostate cancer MRI and their impact on patient care

    Prostate cancer (PCa) remains the leading malignancy affecting men, with over 3 million men living with the disease in the US, and an estimated...

    Eduardo Thadeu de Oliveira Correia, Atallah Baydoun, ... Leonardo Kayat Bittencourt in Abdominal Radiology
    Article Open access 14 June 2024
  14. Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk

    Introduction

    Identifying individual characteristics or underlying conditions linked to adverse drug reactions (ADRs) can help optimise the...

    Olivia Mahaux, Greg Powell, ... Andrew Bate in Drug Safety
    Article Open access 02 May 2023
  15. Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials

    Introduction

    Secukinumab is an anti-interleukin (IL)-17A monoclonal antibody indicated for multiple immunological disorders. Here, we aim to summarize...

    Rui Sun, Mercedes Bustamante, ... Victor Dong in Dermatology and Therapy
    Article Open access 07 March 2024
  16. Use of artificial intelligence in discerning the need for prostate biopsy and readiness for clinical practice: a systematic review protocol

    Background

    Variability and inaccuracies in the diagnosis of prostate cancer, and the risk of complications from invasive tests, have been extensively...

    Elisa Martinez-Marroquin, Minh Chau, ... Catherine Paterson in Systematic Reviews
    Article Open access 17 July 2023
  17. Unusual Presentation of Concurrent Cutaneous Plasmablastic Lymphoma and Acute Myeloid Leukemia: a Case Report and a Comprehensive Review

    Plasmablastic lymphoma (PBL) is a rare type of non-Hodgkin’s lymphoma, primarily seen in patients with immunosuppression, particularly HIV. It...

    Vedant Shah, Harsh Patel, ... Yashash D. Pathak in SN Comprehensive Clinical Medicine
    Article 14 August 2023
  18. Clear cell adenocarcinoma of the male urethra: a case report

    Background

    Primary urethral cancer in males is rare. Clear cell adenocarcinoma is more rare. We report a case in an African male suspected to have a...

    Sikiru A. Adebayo, Ijeoma N. C. Chibuzo, ... Olayiwola B. Shittu in African Journal of Urology
    Article Open access 21 June 2022
  19. Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules

    Background

    Paneth cell-like granules (PCLG) in clear cell renal cell carcinomas (RCC) have previously been reported but were not found to express...

    Vasudevan D. Mahalingam, Oumaima S. Chaib, ... ** L. Zhang in International Urology and Nephrology
    Article 30 September 2023
Did you find what you were looking for? Share feedback.